2021 annual financial data
Kymera Therapeutics 2021 Operating margin
Direct answer
Operating margin was -138.03%.
Operating income was -100,530,000 USD and net income was -100,217,000 USD.
Operating cash flow was -128,946,000 USD.
Get free Kymera Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 72,832,000 USD
- Operating income
- -100,530,000 USD
- Net income
- -100,217,000 USD
- Operating cash flow
- -128,946,000 USD